Found: 16
Select item for more details and to access through your institution.
Medication Discrepancies and Regimen Complexity in Decompensated Cirrhosis: Implications for Medication Safety.
- Published in:
- Pharmaceuticals (14248247), 2021, v. 14, n. 12, p. 1207, doi. 10.3390/ph14121207
- By:
- Publication type:
- Article
Development and Evaluation of the Supportive Needs Assessment Tool for Cirrhosis (SNAC).
- Published in:
- Patient Preference & Adherence, 2020, v. 14, p. 599, doi. 10.2147/PPA.S236818
- By:
- Publication type:
- Article
Poor disease knowledge is associated with higher healthcare service use and costs among patients with cirrhosis: an exploratory study.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Managing medicines in alcohol-associated liver disease: a practical review.
- Published in:
- Australian Prescriber, 2021, v. 44, n. 3, p. 96, doi. 10.18773/austprescr.2021.015
- By:
- Publication type:
- Article
An exploration of barriers and facilitators to implementing a nonalcoholic fatty liver disease pathway for people with type 2 diabetes in primary care.
- Published in:
- Diabetic Medicine, 2022, v. 39, n. 6, p. 1, doi. 10.1111/dme.14799
- By:
- Publication type:
- Article
Effectiveness of patient‐oriented education and medication management intervention in people with decompensated cirrhosis.
- Published in:
- Internal Medicine Journal, 2020, v. 50, n. 9, p. 1142, doi. 10.1111/imj.14986
- By:
- Publication type:
- Article
Underappreciation of non‐alcoholic fatty liver disease by primary care clinicians: limited awareness of surrogate markers of fibrosis.
- Published in:
- Internal Medicine Journal, 2018, v. 48, n. 2, p. 144, doi. 10.1111/imj.13667
- By:
- Publication type:
- Article
Optimising care of patients with chronic disease: patient-oriented education may improve disease knowledge and self-management.
- Published in:
- Internal Medicine Journal, 2017, v. 47, n. 8, p. 952, doi. 10.1111/imj.13505
- By:
- Publication type:
- Article
Can paracetamol (acetaminophen) be administered to patients with liver impairment?
- Published in:
- British Journal of Clinical Pharmacology, 2016, v. 81, n. 2, p. 210, doi. 10.1111/bcp.12802
- By:
- Publication type:
- Article
Advances in the treatment of chronic liver diseases - implications for pharmacy practice from a gastroenterology conference.
- Published in:
- Journal of Pharmacy Practice & Research, 2017, v. 47, n. 6, p. 483, doi. 10.1002/jppr.1325
- By:
- Publication type:
- Article
Changing Prevalence of Medication Use in People with Cirrhosis: A Retrospective Cohort Study Using Pharmaceutical Benefits Scheme Data.
- Published in:
- Drugs - Real World Outcomes, 2023, v. 10, n. 4, p. 605, doi. 10.1007/s40801-023-00390-2
- By:
- Publication type:
- Article
Lower prevalence of elevated liver stiffness measurements in people with type 2 diabetes taking sodium-glucose co-transporter 2 inhibitors or glucagon-like peptide-1 receptor agonists.
- Published in:
- Annals of Hepatology: Official Journal of the Mexican Association of Hepatology, 2023, v. 28, n. 6, p. 1, doi. 10.1016/j.aohep.2023.101142
- By:
- Publication type:
- Article
Implementing the right care in the right place at the right time for non-alcoholic fatty liver disease (NAFLD-RRR study): a study protocol for a community care pathway for people with type 2 diabetes.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Prevalence of medication discrepancies in patients with cirrhosis: a pilot study.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Patient-oriented education and medication management intervention for people with decompensated cirrhosis: study protocol for a randomized controlled trial.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Alcohol Consumption in Diabetic Patients with Nonalcoholic Fatty Liver Disease.
- Published in:
- Canadian Journal of Gastroenterology & Hepatology, 2017, p. 1, doi. 10.1155/2017/7927685
- By:
- Publication type:
- Article